Prognostic factors for long-term outcomes in relapsing-remitting multiple sclerosis.

Area of Science:

• Neurology
• Neuroimmunology
• Radiology

Background:

• Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
• Predicting long-term disability progression in MS is crucial for patient management.
• Identifying reliable prognostic markers remains an ongoing challenge in MS research.

Purpose of the Study:

• To investigate clinical and MRI predictors of long-term outcomes in multiple sclerosis (MS).
• To identify factors that may indicate higher risk of disability progression in MS patients.

Main Methods:

• Post hoc analysis of 382 patients from the PRISMS long-term follow-up study (up to 8 years).
• Analysis included baseline variables, early clinical/MRI activity (0-24 months), and interferon beta-1a (IFN β-1a) treatment exposure (MPR).
• Univariate and stepwise multiple regression models were used to identify prognostic factors.

Main Results:

• Selected prognostic factors included age, MS duration, baseline brain volume, EDSS score, and log(T2 Burden of Disease).
• Higher baseline brain volume and MPR predicted better long-term clinical outcomes.
• Higher baseline and early increase in EDSS score predicted worse long-term outcomes.

Conclusions:

• Baseline brain volume and MPR are potential positive predictors of long-term outcomes in MS.
• EDSS score changes are significant negative predictors of long-term outcomes in MS.
• Identifying prognostic markers can aid in stratifying MS patients by disability progression risk.